2003/10/01 by Londa Schiebinger · 3 citations
Medicine · Economics, Econometrics and Finance · #Sex and Gender in Healthcare #Health and Medical Research Impacts #Health Systems, Economic Evaluations, Quality of Life
paper · pdf · doi:10.1172/jci19993
openalex publication_date 2003/10/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
Women have traditionally been underrepresented in clinical trials. In order to translate recent advances in our understanding of the molecular and physiological bases of sex differences into new therapeutics and health practices, sound sex-specific clinical data are imperative. Since the founding of the Office of Research on Women's Health within the Office of the Director at the NIH in 1990, inequities in federally funded biomedical research, diagnosis, and treatment of diseases affecting women in the US have been reviewed. Discussed herein is the evolution of gender-related research innovations, primarily within the last decade, and strategies and challenges involved in the success of this recent development.